Phenolic complex therapy for attention in children with Down syndrome
Part of Brain & nervous system, Genetic & congenital clinical trials.
This trial tests a natural phenolic complex (K110-42) to see if it can improve attention and focus in children with Down syndrome. It may help if your child struggles with concentration and is between 4 and 8 years old.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have a genetic diagnosis of Down syndrome (Trisomy 21).
- Your child must be between 4 and 8 years old.
- Your child has trouble with attention or focus, as reported by you or a doctor.
- Your child cannot have other serious neurological conditions like autism or epilepsy.
- Your child cannot be on ADHD medications or cognitive-enhancing supplements.
- Your child must have an IQ of 55% or higher.
- Your child cannot have hypothyroidism or certain chronic health issues like liver, kidney, or autoimmune disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medicine called memantine (already used for memory problems) can help people with Down syndrome think and remember better. Researchers will try different doses to find what works best and is safest.
This trial tests whether a medication called bumetanide can improve thinking and learning skills in teenagers with Down syndrome. It is a 10-week study that compares bumetanide to a placebo (a pill with no medicine).
This trial checks whether a “NIH Toolbox” set of child-friendly tests can detect changes when stimulant medicine is used for ADHD. It may help doctors better measure how well stimulant treatment is working in people with intellectual disability.
This study tests whether a supplement that boosts a natural substance called NAD (which helps cells work properly) can slow or stop memory loss in people with Down syndrome. You and your caregiver would visit a clinic for regular checkups and take the supplement daily.
This trial tests an experimental drug (EB-1020) for children with ADHD. It aims to see if the drug is safe and effective in reducing ADHD symptoms.
This study tests if an investigational drug called AEF0217 can help improve thinking and daily living skills in people with Down syndrome. It's for ages 16-32 who have a caregiver to support them throughout the trial.
Hear when a new Cognitive Functions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.